You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches
Pulmonology

ERS 2024 | What Do We Know About IL-33 Genetics?

Dr. Stephanie Christenson examines the genetic and environmental factors influencing IL-33 expression and activity in COPD, highlighting the complex interplay between genetics, smoking, and disease pathogenesis.

Stephanie Christenson
MD, MAS
Stephanie Christenson

Learning objectives

  • Provide evidence on the genetic association of IL-33 and COPD and early preclinical results Topic: Burden of disease; pathophysiology
Tags
quality of lifemechanism of diseasechronic inflammationheterogeneity
MAT-GLB-2406273 - 1.0 - 10/2024

About this expert

Pulmonology

Stephanie Christenson

MD, MAS

Associate Professor at the University of California, San Francisco in the Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine

See author’s profile
Stephanie Christenson

Related resources

GINA-Based Opportunities for Improved Outcomes With Effective Management of Pediatric Asthma in Children 6-11 Years of Age
Pulmonology
interactivity

GINA-Based Opportunities for Improved Outcomes With Effective Management of Pediatric Asthma in Children 6-11 Years of Age

GOLD 2024 Diagnosis and Assessment of COPD
Pulmonology
expert video

GOLD 2024 Diagnosis and Assessment of COPD

Importance of Lung Function Assessment in Pediatric Asthma Patients
Pulmonology
videoanimation

Importance of Lung Function Assessment in Pediatric Asthma Patients

ADVENT On Air | What Is the Future Outlook for Remission in Pediatric Severe Asthma?
Pulmonology
Podcast

ADVENT On Air | What Is the Future Outlook for Remission in Pediatric Severe Asthma?

Lung Function Assessment Is a Fundamental Component of Optimal Asthma Care
Pulmonology
videoanimation

Lung Function Assessment Is a Fundamental Component of Optimal Asthma Care

How Can Poor Lung Function Impact Asthma Burden in Pediatric Patients?
Pulmonology
videoanimation

How Can Poor Lung Function Impact Asthma Burden in Pediatric Patients?

EAACI 2024 Moving Beyond Control To On-Treatment Clinical Remission
Pulmonology
expert video

EAACI 2024 Moving Beyond Control To On-Treatment Clinical Remission

EAACI 2024 Emerging Definitions of Clinical Remission and Achieving Clinical Remission With Biologics for Patients With Asthma
Pulmonology
expert video

EAACI 2024 Emerging Definitions of Clinical Remission and Achieving Clinical Remission With Biologics for Patients With Asthma

EAACI 2024 Evolving Perspectives in CRSwNP Patient Care
Pulmonology
expert video

EAACI 2024 Evolving Perspectives in CRSwNP Patient Care

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma
Pulmonology
Podcast

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma

ERS 2024 | Understanding the Complex Pathophysiology of COPD
Pulmonology
expert video

ERS 2024 | Understanding the Complex Pathophysiology of COPD

COPD and Asthma: What's the Difference and Is There a Link?
Pulmonology
interactivity

COPD and Asthma: What's the Difference and Is There a Link?

Type 2 Inflammation Digital Assessment Tool
Pulmonology
interactivity

Type 2 Inflammation Digital Assessment Tool

Chronic Obstructive Pulmonary Disease: Disease Burden & Heterogeneity
Pulmonology
interactivity

Chronic Obstructive Pulmonary Disease: Disease Burden & Heterogeneity

ERS 2023 | The Impact of Type 2 Inflammation on COPD: Examining Its Role in Disease Pathophysiology
Pulmonology
expert video

ERS 2023 | The Impact of Type 2 Inflammation on COPD: Examining Its Role in Disease Pathophysiology

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD
Pulmonology
expert video

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

GOLD 2023 | Role of Underlying Inflammation in COPD Pathology and Clinical Features
Pulmonology
expert video

GOLD 2023 | Role of Underlying Inflammation in COPD Pathology and Clinical Features

What Are the Key Inflammatory Processes in Patients with COPD?
Pulmonology
expert video

What Are the Key Inflammatory Processes in Patients with COPD?

How Can FeNO Measurement Improve Severe Asthma Management?
Pulmonology
expert video

How Can FeNO Measurement Improve Severe Asthma Management?

How Can Poor Lung Function Impact Asthma Burden in Adult Patients?
Pulmonology
videoanimation

How Can Poor Lung Function Impact Asthma Burden in Adult Patients?

Importance of Lung Function Assessment in Adult Asthma Patients
Pulmonology
videoanimation

Importance of Lung Function Assessment in Adult Asthma Patients

Monitoring Lung Function Is an Important Aspect of Pediatric Asthma Management
Pulmonology
interactivity

Monitoring Lung Function Is an Important Aspect of Pediatric Asthma Management

Mucus Plugging Is a Key Component of Remodeling in Asthma, Leading to Fixed Airway Obstruction
Pulmonology
Infographic

Mucus Plugging Is a Key Component of Remodeling in Asthma, Leading to Fixed Airway Obstruction

On-Treatment Clinical Remission in Asthma Patients Case Tool
Pulmonology
interactivity

On-Treatment Clinical Remission in Asthma Patients Case Tool

Type 2 Inflammation Is a Significant Driver of Pediatric Severe Asthma
Pulmonology
Infographic

Type 2 Inflammation Is a Significant Driver of Pediatric Severe Asthma

Type 2 Inflammation Mediates Severe Asthma in Pediatric Patients
Pulmonology
expert video

Type 2 Inflammation Mediates Severe Asthma in Pediatric Patients

What is the Role of FeNO as an Asthma Biomarker?
Pulmonology
expert video

What is the Role of FeNO as an Asthma Biomarker?

ERS 2024 | Panel Discussion: What Might Be Required for On-Therapy Remission in Pediatric Severe Asthma?
Pulmonology
expert video

ERS 2024 | Panel Discussion: What Might Be Required for On-Therapy Remission in Pediatric Severe Asthma?

ADVENT On Air | Breathing Easy: Navigating Lung Function in Pediatric Severe Asthma With Spirometry and Beyond
Pulmonology
Podcast

ADVENT On Air | Breathing Easy: Navigating Lung Function in Pediatric Severe Asthma With Spirometry and Beyond

Worsening Disease Results in a Vicious Cycle of COPD
Pulmonology
interactivity

Worsening Disease Results in a Vicious Cycle of COPD

Blood Eosinophils: A Biomarker in COPD
Pulmonology
Infographic

Blood Eosinophils: A Biomarker in COPD

GOLD 2023 | Clinical Presentation of COPD and Disease Burden
Pulmonology
expert video

GOLD 2023 | Clinical Presentation of COPD and Disease Burden

Pathways to Disease: Inflammation in COPD
Pulmonology
interactivity

Pathways to Disease: Inflammation in COPD

What Do We Know About Type 2 Inflammation in COPD?
Pulmonology
expert video

What Do We Know About Type 2 Inflammation in COPD?

What Differentiates COPD Exacerbations From Asthma Exacerbations?
Pulmonology
expert video

What Differentiates COPD Exacerbations From Asthma Exacerbations?

The Heterogeneity of Underlying Inflammation in Patients With COPD
Pulmonology
expert video

The Heterogeneity of Underlying Inflammation in Patients With COPD

ERS 2023 | Contextualizing Clinical Presentation of COPD Through Disease Pathology
Pulmonology
expert video

ERS 2023 | Contextualizing Clinical Presentation of COPD Through Disease Pathology

ERS 2023 | Heterogeneity of Inflammatory Pathways in COPD
Pulmonology
expert video

ERS 2023 | Heterogeneity of Inflammatory Pathways in COPD

ERS 2024 | What Do We Know About IL-33 Genetics?
Pulmonology
expert video

ERS 2024 | What Do We Know About IL-33 Genetics?

Pathways to Disease: Inflammation in Chronic Obstructive Pulmonary Disease Video
Pulmonology
videoanimation

Pathways to Disease: Inflammation in Chronic Obstructive Pulmonary Disease Video

ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?
Pulmonology
expert video

ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

ADVENT On Air | Diving Deep: Exploring the Impact of Airway Remodeling in Severe Asthma
Pulmonology
Podcast

ADVENT On Air | Diving Deep: Exploring the Impact of Airway Remodeling in Severe Asthma

ERS 2024 | Understanding Remission as a Treatment Goal in Pediatric Severe Asthma – Patient Case Introduction
Pulmonology
expert video

ERS 2024 | Understanding Remission as a Treatment Goal in Pediatric Severe Asthma – Patient Case Introduction

ERS 2024 | How Can Biologics Help Achieve Clinical Remission in Children With Severe Asthma?
Pulmonology
expert video

ERS 2024 | How Can Biologics Help Achieve Clinical Remission in Children With Severe Asthma?

ERS 2024 | Understanding Remission as a Treatment Goal in Pediatric Severe Asthma – Patient Case Follow-Up
Pulmonology
expert video

ERS 2024 | Understanding Remission as a Treatment Goal in Pediatric Severe Asthma – Patient Case Follow-Up

ERS 2024 | Pediatric Severe Asthma: Is Clinical Remission Possible?
Pulmonology
expert video

ERS 2024 | Pediatric Severe Asthma: Is Clinical Remission Possible?

ERS 2024 | Pathophysiologic Mechanisms of Airway Remodeling in Severe Asthma
Pulmonology
expert video

ERS 2024 | Pathophysiologic Mechanisms of Airway Remodeling in Severe Asthma

ERS 2024 | Living With COPD: Linking Inflammation with Patient Burden
Pulmonology
expert video

ERS 2024 | Living With COPD: Linking Inflammation with Patient Burden

Why Is It Important to Assess Lung Function in Pediatric Asthma
Pulmonology
interactivity

Why Is It Important to Assess Lung Function in Pediatric Asthma

Type 2 Inflammation and Airway Remodeling Drive Lung Function Decline
Pulmonology
videoanimation

Type 2 Inflammation and Airway Remodeling Drive Lung Function Decline

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: AlgeriaChange country/region